Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT04140578
Recruiting Phase 4

Antibiotic Prophylaxis in Patients Undergoing GVO

NCT04140578 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Taipei Veterans General Hospital, Taiwan
Phase
Phase 4
Started
2017-01-28
Last updated
2019-10-28

Condition(s) studied

Gastric VarixSepsisLiver CirrhosesFever

Investigational drug(s) / intervention(s)

Ertapenem →

Ertapenem: inject from iv drip before endoscopic cyanoacrylateinjection obliteration

Study summary

We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.

Eligibility

Sex
ALL
Min age
20 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients with live cirrhosis and/or hepatoma 2. Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV Exclusion Criteria: 1. Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD 2. Patients recieve antibiotics recently. 3. Patients suspected infection.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Veteran General Hospital-Taipei Taipei Taiwan Recruiting

More Taipei Veterans General Hospital, Taiwan trials in Taiwan

Atrial Remodeling After PFA Substrate Modification for Persistent AF (PeAF) Starting soon
Explore Neural Mechanism of Obsessive-Compulsive Disorder (OCD) by Intervention of Repetitive Transcranial Magnetic Stimulation With Symptom Provocation Recruiting
Utility of Analyzing Atrial Signal Electrograms in Patients with Atrial Fibrillation Using Next-Generation Ensite X Software: a Prospective Study Active, not recruiting
Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) Recruiting
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial) Recruiting

Other trials for the same condition

PRIME Sepsis Trial: Early Sepsis Detection in the Emergency Department Using Presepsin and Immature Granulocytes Starting soon
Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized Patients Active, not recruiting
Early Sepsis Recognition Tool Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04140578 on ClinicalTrials.gov ↗ ← All trials in Taiwan